Cancer Stem Cells: Controversial or Just Misunderstood?

James P. Wilmot Cancer Center, University of Rochester, 601 Elmwood Avenue, Box 704, Rochester, NY 14642, USA.
Cell stem cell (Impact Factor: 22.15). 04/2009; 4(3):203-5. DOI: 10.1016/j.stem.2009.02.003
Source: PubMed

ABSTRACT While a broad range of expertise has recently come to bear on the intriguing topic of "cancer stem cells," the overall relevance of stem cells as they relate to cancer remains in dispute. In this commentary, underlying points of contention are described with the aim of defining focal points for discussion and future consideration.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Development of resistance limits transferability of most anticancer therapies into curative treatment and understanding mechanisms beyond it remains a big challenge. Many high resolution experimental observations show enormous intratumor heterogeneity at molecular, genetic and cellular levels which is made responsible for emerging resistance to therapy. Therefore, researchers search techniques to influence development of intratumor heterogeneity, which requires understanding its role within the context of integrative, logically consistent, framework, such as evolutionary theory. Although it is agreed that intratumor heterogeneity increases probability of the emergence of therapy resistant clones, more instructive role of its structure in the process of cancer dynamics and metastasis is needed. In the paper, intratumor heterogeneity is viewed as a product of two, in general stochastic, processes, evolutionary optimization and changing environment, respectively. In evolutionary theory, common risk-diversifying strategy displayed by isogenic populations in unpredictably changing environments is bet-hedging. We suggest, that the structure of intratumor heterogeneity is evolutionary trait evolving to maximize the clonal fitness in changing (or uncertain) environment and that its structure corresponds to bet-hedging strategy. We advocate our view by reviewing and combining important cancer relevant concepts.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The biological functional roles of LGR5 (leucine-rich repeat containing G protein-coupled receptor 5, also known as GPR49), a novel potential marker for stem-like cells in glioblastoma (GSCs), is poorly acknowledged. Here, we demonstrated that LGR5 was detected in glioblastoma tissues and GSCs. Bioinformatics analysis revealed that LGR5 is closely related to neurogenesis and neuronal functions, and preferentially expressed in Proneural subtype of GBMs. Furthermore, LGR5 is regulated by Proneural factor OLIG2, which is important for both neurogenesis and GSC maintenance. Biological experiments in GSC cells validated the bioinformatics analysis results and revealed that LGR5 regulated the tumor sphere formation capacity, an important stem cell property for GSCs. Therefore, LGR5 expression may be functionally correlated with the neurogenic competence, and be regulated by OLIG2 in GSCs.
    Cellular and Molecular Neurobiology 06/2013; 33(6). DOI:10.1007/s10571-013-9951-6 · 2.20 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Eighty percent of malignant tumors that develop in the central nervous system are malignant gliomas, which are essentially incurable. Here, we discuss how recent sequencing studies are identifying unexpected drivers of gliomagenesis, including mutations in isocitrate dehydrogenase 1 and the NF-κB pathway, and how genome-wide analyses are reshaping the classification schemes for tumors and enhancing prognostic value of molecular markers. We discuss the controversies surrounding glioma stem cells and explore how the integration of new molecular data allows for the generation of more informative animal models to advance our knowledge of glioma's origin, progression, and treatment.
    Cell 03/2012; 149(1):36-47. DOI:10.1016/j.cell.2012.03.009 · 33.12 Impact Factor


Available from